Pharmaceutical stocks continued to rise in the afternoon. As of press release, Dongguang Changjiang Pharmaceutical (01558) rose 6.8% to HK$9.27; Hehuang Pharmaceutical (00013) rose 4.87% to HK$30.15; Sansheng Pharmaceutical (01530) rose 3.77% to HK$7.43; and Shiyao Group (01093) rose 2.63% to HK$7.03.
The Zhitong Finance App learned that pharmaceutical stocks continued to rise in the afternoon. As of press release, Dongguang Changjiang Pharmaceutical (01558) rose 6.8% to HK$9.27; Hehuang Pharmaceutical (00013) rose 4.87% to HK$30.15; Sansheng Pharmaceutical (01530) rose 3.77% to HK$7.43; and Shiyao Group (01093) rose 2.63% to HK$7.03.
According to the news, recently, the Beijing Center for Disease Control and Prevention said that at present, Beijing has entered a season of high incidence of respiratory infectious diseases, showing a trend of common prevalence of various pathogens. Influenza is in the epidemic period, and the number of cases is rising rapidly. The top three reported cases of respiratory infectious diseases in the entire population in Beijing are: influenza, rhinovirus, and respiratory syncytial virus.
The pharmaceutical biology team of Huaan Securities said that the current disadvantages related to pharmaceutical industry policies have come to an end, funds and other institutions have increased month-on-month in pharmaceutical positions. Recently, respiratory diseases such as influenza and pulmonary bronchial coats have been frequent, so it is recommended to focus on related stocks.